Heme oxygenase in regulation of renal function and blood pressure

Current Hypertension Reviews

Volumn 5, Issue 1, 2009, Pages 13-23

  Botros, Fady T ^a   Navar, L Gabriel ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

19 HYDROXYICOSATETRAENOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; ANGIOTENSIN II; BILIVERDIN; CARBON MONOXIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; CYTOCHROME P450 4A; CYTOCHROME P450 ARACHIDONIC ACID; DEOXYCORTICOSTERONE ACETATE; DEUTEROPORPHYRIN DERIVATIVE; HEME OXYGENASE 1; HEME OXYGENASE 2; HYDROXYICOSATETRAENOIC ACID; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; ZINC DEUTEROPORPHYRIN;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLOOD PRESSURE REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; HEME SYNTHESIS; HENLE LOOP; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVIEW; SALT INTAKE; SMOOTH MUSCLE FIBER; SODIUM ABSORPTION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 65949088334     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340209787314298     Document Type: Review

References (134)

1. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968; 61: 748-55.
2. Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 1969; 244: 6388-94.
3. Maines MD, Kappas, A. Metals of regulators of heme metabolism. Science 1977; 198: 1215-21.
4. Abraham NG, Drummond GS, Lutton JD, Kappas A. The biological significance and physiological role of heme oxygenase. Cell Physiol Biochem 1996; 6: 129-68.
5. Abraham NG, Lin JH, Schwartzman ML, Levere RD, Shibahara S. The physiological significance of heme oxygenase. Int J Biochem 1988; 20: 543-58.
6. Johnson R A, Lavesa M, DeSeyn K, Scholer MJ, Nasjletti A. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J Physiol 1996; 271: H1132-H1138.
7. Johnson RA, Lavesa M, Askari B, Abraham NG, Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 1995; 25: 166-69.
8. Martasek P, Schwartzman ML, Goodman AI, Solangi KB, Levere RD, Abraham NG. Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats. J Am Soc Nephrol 1991; 2: 1078-84.
9. Levere RD, Martasek P, Escalante B, Schwartzman ML, Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest 1990; 86: 213-19.
10. Maines MD. The heme oxygenase system; a regulator of second messenger gases. Ann Rev Pharmacol Toxicol 1997; 37: 517-54.
11. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 1989; 243: 388-90.
12. Laniado-Schwartzman M, Abraham NG, Sacerdoti D, Escalante B, McGiff JC. Effect of acute and chronic treatment of tin on blood pressure in spontaneously hypertensive rats. Tohoku J Exp Med 1992; 166: 85-91.
13. Pimstone RN, Engel P, Tenhunen R, Schmid R. Inducible heme oxygenase in the kidney: A model for the homeostatic control of hemoglobin catabolism. J Clin Invest 1971; 50: 2042-50.
14. Shibahara S, Yoshizawa M, Suzuki H, Takeda K, Meguro K, Endo K. Functional analysis of cDNAs for two types of human heme oxygenase and evidence for their separate regulation. J Biochem Tokyo1993; 113: 214-18.
15. Muller RM, Taguchi H, Shibahara, S. Nucleotide sequence and organization of the rat heme oxygenase gene. J Biol Chem 1987; 262: 6795-802.
16. McCoubrey WK, Jr, Ewing JF, Maines, MD. Human heme oxygenase-2: characterization and expression of a full-length cDNA and evidence suggesting that the two HO-2 transcripts may differ by choice of polyadenylation signal. Arch Biochem Biophys 1992; 295: 13-20.
17. Hu Y, Ma N, Yang M, Semba R. Expression and distribution of heme oxygenase-2 mRNA and protein in rat kidney. J Histochem Cytochem 1998; 46: 249-56.
18. da Silva JL, Zand BA, Yang LM, Sabaawy HE, Lianos E, Abraham NG. Heme oxygenase isoform-specific expression and distribution in the rat kidney. Kidney Int 2001; 59: 1448-57.
19. Botros FT, Laniado-Schwartzman M, Abraham NG. Regulation of cyclooxygenase- and cytochrome p450-derived eicosanoids by heme oxygenase in the rat kidney. Hypertension 2002; 39: 639-44.
20. Kappas A, Maines MD. Tin: a potent inducer of heme oxygenase in kidney. Science 1976; 192: 60-2.
21. Kappas A, Drummond G. Control of heme metabolism with synthetic metalloporphyrins. J Clin Invest 1986; 77: 335-39.
22. Nath KA, Vercellotti GM, Grande JP, et al. Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int. 2001; 59: 106-17.
23. Nath KA, Croatt AJ, Haggard JJ, Grande JP. Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult. Kidney Int. 2000; 57: 2423-33.
24. Nath KA, Balla J, Jacob HS, Vercellotti GM, Levitt M, Rosenberg ME. Induction of heme oxygenase is a rapid protective response in rhabdomyolysis in the rat. J Clin Invest 1992; 90: 267-70.
25. Stocker R. Induction of haem oxygenase as a defense against oxidative stress. Free Radic Res Commun 1990; 9: 101-12.
26. Shepard M, Dhulipala P, Kabaria S, Abraham NG, Lianos EA. Heme oxygenase-1 localization in the rat nephron. Nephron 2002; 92: 660-64.
27. Abraham NG, Botros FT, Rezzani R, Rodella L, Bianchi R, Goodman AI. Differential effect of cobalt protoporphyrin on distributions of heme oxygenase in renal structure and on blood pressure in SHR. Cell Mol Biol(Noisy.-le-grand) 2002; 48: 895-902.
28. Vogt BA, Alam J, Croatt AJ, Vercellotti GM, Nath KA. Acquired resistance to acute oxidative stress. Possible role of heme oxygenase and ferritin. Lab Invest 1995; 72: 474-83.
29. Agarwal A, Balla J, Alam J, Croatt AJ, Nath KA. Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int 1995; 48: 1298-307.
30. Sikorski EM, Hock T, Hill-Kapturczak N, Agarwal A. The story so far: Molecular regulation of the heme oxygenase-1 gene in renal injury. Am J Physiol Renal Physiol 2004; 286: F425-F441.
31. Hill-Kapturczak N, Chang SH, Agarwal A. Heme oxygenase and the kidney. DNA Cell Biol 2002; 21: 307-21.
32. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science (Washington DC) 1987; 235: 1043-47.
33. Eisenstein RS, Garcia-Mayol D, Pettingell W, Munro HN. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci USA 1991; 88: 688-92.
34. Sammut IA, Foresti R, Clarck JE, et al. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol 1998; 125: 1437-44.
35. Furchgott RF, Jothianandan D. Endothelium-dependent and independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 1991; 28: 52-61.
36. Morita T, Perrella MA, Lee M, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 1995; 92: 1475-79.
37. Wang R, Wu L. The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Pfluegers Arch 1997; 434: 285-91.
38. Zhang F, Kaide JI, Rodriguez-Mulero F, Abraham NG, Nasjletti A. Vasoregulatory function of the heme-heme oxygenase-carbon monoxide system. Am J Hypertens 2001; 14: 62S-7S.
39. Kozma F, Johnson RA, Zhang F, Yu C, Tong X, Nasjletti A. Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am J Physiol 1999; 276: R1087-R1094.
40. Kaide JI, Zhang F, Wei Y, et al. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 2001; 107: 1163-71.
41. Hirakawa H, Hayashida Y. Autonomic cardiovascular responses to heme oxygenase inhibition in conscious rats. Hypertension 2006; 48: 1124-29.
42. Johnson RA, Colombari E, Colombari DSA, Lavesa M. Role of endogenous carbon monoxide in central regulation of arterial pressure. Hypertension 1997; 30: 962-67.
43. Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, Winslow RM. Heme oxygenase-1 derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 1998; 83: 568-77.
44. Peyton KJ, Reyna SV, Chapman GB, et al. Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 2002; 99: 4443-48.
45. Morita T, Mitsialis SA, Koike H, Liu Y, Kourembanas S. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 1997; 272: 32804-09.
46. Togane Y, Morita T, Suematsu M, Ishimura Y, Yamazaki JI, Katayama S. Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am J Physiol Heart Circ Physiol 2000; 278: H623-H632.
47. Durante W. Carbon monoxide and bile pigments: surprising mediators of vascular function. Vasc Med 2002; 7: 195-202.
48. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 1995; 96: 2676-82.
49. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015-26.
50. Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, Soares MP. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem 2002; 277: 17950-61.
51. Deramaudt BM, Braunstein S, Remy P, Abraham NG. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 1998; 68: 121-27.
52. Li Volti G, Wang J, Traganos F, Kappas A, Abraham NG. Differential effect of heme oxygenase-1 in endothelial and vascular smooth muscle cell cycle progression. Biochem Biophys Res Commun 2002; 296: 1077-82.
53. Malaguarnera L, Pilastro MR, Quan S, et al. Significance of heme oxygenase in prolactin-mediated cell proliferation and angiogenesis in human endothelial cells. Int J Mol Med 2002; 10: 433-40.
54. Dulak J, Jozkowicz A, Foresti R, et al. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 2002; 4: 229-40.
55. Inguaggiato P, Gonzalez-Michaca L, Croatt AJ, Haggard JJ, Alam J, Nath KA. Cellular overexpression of heme oxygenase-1 upregulates p21 and confers resistance to apoptosis. Kidney Int 2001; 60: 2181-91.
56. Gonzalez-Michaca L, Farrugia G, Croatt AJ, Alam J, Nath KA. Heme: a determinant of life and death in renal tubular epithelial cells. Am J Physiol Renal Physiol 2004; 286: F370-F377.
57. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen- activated protein kinase pathway. Nat Med 2000; 6: 422-28.
58. Brune B, Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 1987; 32: 497-504.
59. Wagener FADTG, da Silva J-L, Farley T, de Witte T, Kappas A, Abraham NG. Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther 1999; 291: 416-23.
60. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1029-L1037.
61. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 1994; 269: 16712-19.
62. Vachharajani TJ, Work J, Issekutz AC, Granger DN. Heme oxygenase modulates selectin expression in different regional vascular beds. Am J Physiol Heart Circ Physiol 2000; 278: H1613-H1617.
63. Dore S, Takahashi M, Ferris CD, et al. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 1999; 96: 2445-50.
64. Clark JE, Foresti R, Green CJ, Motterlini R. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 2000; 348(Pt 3): 615-19.
65. Kwak JY, Takeshige K, Cheung BS, Minakami S. Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. Biochim Biophys Acta 1991; 1076: 369-73.
66. Sano K, Nakamura H, Matsuo T. Mode of inhibitory action of bilirubin on protein kinase C. Pediatr Res 1985; 19: 587-90.
67. Jiang F, Roberts SJ, Datla S, Dusting GJ. NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 2006; 48: 950-57.
68. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, Jiang, F. Induction of heme oxygenase-1 in vivo suppresses nadph oxidase derived oxidative stress. Hypertension 2007; 50(4): 636-42.
69. McGiff JC. Cytochrome P-450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol 1991; 31: 339-69.
70. McGiff JC, Quilley J. 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr Opin Nephrol Hypertens 2001; 10: 231-37.
71. Schwartzman ML, Falck JR, Yadagiri P, Escalante B. Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites. J Biol Chem 1989; 264: 11658-62.
72. Ma YH, Gebremedhin D, Schwartzman ML, et al. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 1993; 72: 126-36.
73. Zou AP, Fleming JT, Falck JR, et al. 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles. Am J Physiol 1996; 270: R228-R237.
74. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol 1996; 270: R217-R227.
75. Zou AP, Imig JD, Kaldunski M, Ortiz-de-Montellano PR, Sui Z, Roman RJ. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am J Physiol 1994; 266: F275-F282.
76. Zou AP, Imig JD, Ortiz-de-Montellano PR, Sui Z, Falck JR, Roman, RJ. Effect of P-450 omega-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am J Physiol 1994; 266: F934-F941.
77. Lin F, Rios A, Falck JR, Belosludtsev Y, Schwartzman ML. 20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. Am J Physiol 1995; 269: F806-F816.
78. Laniado-Schwartzman M, Abraham NG. The renal cytochrome P450 arachidonic acid system. Pediatr Nephrol 1992; 6: 490-98.
79. Stec DE, Trolliet MR, Krieger JE, Jacob HJ, Roman RJ. Renal cytochrome P4504A activity and salt sensitivity in spontaneously hypertensive rats. Hypertension 1996; 27: 1329-36.
80. Minuz P, Jiang H, Fava C, et al. Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease. Hypertension 2008; 51: 1379-85.
81. Escalante B, Erlij D, Falck JR, McGiff JC. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science 1991; 251: 799-802.
82. Schwartzman M, Ferreri NR, Carroll MA, Songu-Mize E, McGiff JC. Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase. Nature 1985; 314: 620-22.
83. Wang W, Lu M. Effect of arachidonic acid on activity of the apical K+ channel in the thick ascending limb of the rat kidney. J Gen Physiol 1995; 106: 727-43.
84. Zou AP, Drummond HA, Roman RJ. Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats. Hypertension 1996; 27: 631-35.
85. Kaide J, Zhang F, Wei Y, et al. Vascular CO counterbalances the sensitizing influence of 20-HETE on agonist-induced vasoconstriction. Hypertension 2004; 44: 210-16.
86. Chernick RJ, Martasek P, Levere RD, Margreiter R, Abraham NG. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology 1989; 10: 365-69.
87. Smith WL, Bell TG. Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex. Am J Physiol 1978; 235: F451-F457.
88. Harris RC, McKanna JA, Akai Y, Jacobson HR, DuBois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 1994; 94: 2504-10.
89. Vio CP, Cespedes C, Gallardo P, Masferrer JL. Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells. Hypertension 1997; 30: 687-92.
90. Sessa WC, Abraham NG, Escalante B, Schwartzman ML. Manipulation of cytochrome P-450 dependent renal thromboxane synthase activity in spontaneously hypertensive rats. J Hypertens 1989; 7: 37-42.
91. Haider A, Olszanecki R, Gryglewski R, et al. Regulation of cyclooxygenase by the heme-heme oxygenase system in microvessel endothelial cells. J Pharmacol Exp Ther 2002; 300: 188-94.
92. Yang T, Endo Y, Huang YG, Smart A, Briggs JP, Schnermann J. Renin expression in COX-2-knockout mice on normal or low-salt diets. Am J Physiol Renal Physiol 2000; 279: F819-F825.
93. Traynor TR, Smart A, Briggs JP, Schnermann J. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2. Am J Physiol 1999; 277: F706-F710.
94. Thorup C, Jones CL, Gross SS, Moore LC, Goligorsky MS. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol 1999; 277: F882-F889.
95. Stone JR Marletta MA. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 1994; 33: 5636-40.
96. Watts RN, Ponka P, Richardson DR. Effects of nitrogen monoxide and carbon monoxide on molecular and cellular iron metabolism: mirror-image effector molecules that target iron. Biochem J 2003; 369: 429-40.
97. Wu L, Cao K, Lu Y, Wang R. Different mechanisms underlying the stimulation of K(Ca) channels by nitric oxide and carbon monoxide. J Clin Invest 2002; 110: 691-700.
98. Botros FT, Navar LG. Interaction between endogenously produced carbon monoxide and nitric oxide in regulation of renal afferent arterioles. Am J Physiol Heart Circ Physiol 2006; 291: H2772-H2778.
99. Rodriguez F, Lamon BD, Gong W, Kemp R, Nasjletti A. Nitric oxide synthesis inhibition promotes renal production of carbon monoxide. Hypertension 2004; 43: 347-51.
100. Zou AP, Billington H, Su N, Cowley AW, Jr. Expression and actions of heme oxygenase in the renal medulla of rats. Hypertension 2000; 35: 342-47.
101. Rodriguez F, Zhang F, Dinocca S, Nasjletti A. Nitric oxide synthesis influences the renal vascular response to heme oxygenase inhibition. Am J Physiol Renal Physiol 2003; 284: F1255-F1262.
102. Arregui B, Lopez B, Garcia Salom M, Valero F, Navarro C, Fenoy FJ. Acute renal hemodynamic effects of dimanganese decacarbonyl and cobalt protoporphyrin. Kidney Int 2004; 65: 564-74.
103. Appleton SD, Chretien ML, McLaughlin BE, et al. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab Dispos 1999; 27: 1214-19.
104. O'Donaughy TL, Walker BR. Renal vasodilatory influence of endogenous carbon monoxide in chronically hypoxic rats. Am J Physiol Heart Circ Physiol 2000; 279: H2908-H2915.
105. Ryan MJ, Jernigan, NL, Drummond, HA, et al. Renal vascular re sponses to CORM-A1 in the mouse. Pharmacol Res 2006; 54: 24-29.
106. Rodriguez F, Kemp R, Balazy M, Nasjletti A. Effects of exogenous heme on renal function. Role of heme oxygenase and cyclooxygenase. Hypertension 2003; 42: 680-84.
107. Liu H, Mount DB, Nasjletti A, Wang W-H. Carbon monoxide stimulates the apical 70-pS K+ channel of the rat thick ascending limb. J Clin Invest 1999; 103: 963-70.
108. Wang T, Sterling H, Shao WA, Yan Q, Bailey, MA, Giebisch G, Wang WH. Inhibition of heme oxygenase decreases sodium and fluid absorption in the loop of Henle. Am J Physiol Renal Physiol 2003; 285: F484-F490.
109. Li N, Yi F, dos Santos EA, Donley DK, Li PL. Role of renal medullary heme oxygenase in the regulation of pressure natriuresis and arterial blood pressure. Hypertension 2007; 49: 148-54.
110. Nath KA. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 2006; 70: 432-43.
111. Escalante B, Sacerdoti D, Davidian MM, McGiff JC. Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats. Hypertension 1991; 17: 776-79.
112. Sabaawy HE, Zhang F, Nguyen X, et al. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 2001; 38: 210-15.
113. Ndisang JF, Wu L, Zhao W, Wang R. Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats. Blood 2003; 101: 3893-900.
114. Wang R, Shamloul R, Wang X, Meng Q, Wu, L. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 2006; 48: 685-92.
115. Burns KD, Li N. The role of angiotensin II-stimulated renal tubular transport in hypertension. Curr Hypertens Rep 2003; 5: 165-71.
116. Touyz RM. The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 2003; 5: 155-64.
117. Navar LG, Kobori H, Prieto-Carrasquero M. Intrarenal angiotensin II and hypertension. Curr Hypertens Rep 2003; 5: 135-43.
118. Haugen EN, Croatt AJ, Nath KA. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase- 1 in vivo and in vitro. Kidney Int. 2000; 58: 144-52.
119. Aizawa T, Ishizaka N, Taguchi J, et al. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 2000; 35: 800-06.
120. Yang L, Quan S, Nasjletti A, Laniado-Schwartzman M, Abraham NG. Heme oxygenase-1 gene expression modulates angiotensin II-induced increase in blood pressure. Hypertension 2004; 43: 1221-26.
121. Li P, Jiang H, Yang L, et al. Angiotensin II induces carbon monoxide production in the perfused kidney: relationship to protein kinase C activation. Am J Physiol Renal Physiol 2004; 287: F914-F920.
122. Vera T, Kelsen S, Yanes LL, Reckelhoff JF, Stec DE. HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1472-R1478.
123. Quan S, Yang L, Shenouda S, Abraham NG. Expression of human heme oxygenase-1 in renal medullary thick ascending limb attenuates angiotensin II-mediated increase in cyclooxygenase activity. Kidney Int 2004; 65(5): 1628-39.
124. Pflueger A, Croatt AJ, Peterson TE, Smith LA, d'Uscio LV, Katusic ZS, Nath K A. The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II. Am J Physiol Renal Physiol 2005; 288: F552-F558.
125. Adin CA, Croker BP, Agarwal A. Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated perfused rat kidney. Am J Physiol Renal Physiol 2004; 288(4): F778-F784.
126. Stec DE, Vera T, McLemore GR, Jr, Kelsen S, Rimoldi JM, Gadepalli RS, Ryan MJ. Heme oxygenase-1 induction does not improve vascular relaxation in angiotensin II hypertensive mice. Am J Hypertens 2008; 21: 189-93.
127. Wiesel P, Patel AP, Carvajal IM, et al. Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circ Res 2001; 88: 1088-94.
128. Botros FT, Schwartzman ML, Stier CT Jr, Goodman AI, Abraham NG. Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int 2005; 68: 2745-55.
129. Botros FT, Olszanecki R, Prieto-Carrasquero MC, Goodman AI, Navar LG, Abraham NG. Induction of heme oxygenase-1 in renovascular hypertension is associated with inhibition of apoptosis. Cell Mol Biol(Noisy.-le-grand) 2007; 53: 51-60.
130. Johnson FK, Durante W, Peyton KJ, Johnson RA. Heme oxygenase-mediated endothelial dysfunction in DOCA-salt, but not in spontaneously hypertensive, rat arterioles. Am J Physiol Heart Circ Physiol 2004; 286: H1681-H1687.
131. Nath KA, d'Uscio LV, Juncos JP, et al. An analysis of the DOCA-salt model of hypertension in HO-1-/- mice and the Gunn rat. Am J Physiol Heart Circ Physiol 2007; 293: H333-H342.
132. Johnson FK, Durante W, Peyton KJ, Johnson RA. Heme oxygenase inhibitor restores arteriolar nitric oxide function in dahl rats. Hypertension 2003; 41: 149-55.
133. Johnson RA, Teran FJ, Durante W, Peyton KJ, Johnson FK. Enhanced heme oxygenase-mediated coronary vasodilation in Dahl salt-sensitive hypertension. Am J Hypertens 2004; 17: 25-30.
134. Katavetin P, Inagi R, Miyata T, et al. Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 2007; 359: 928-34.